Ipamorelin Protocol
The Sleep Protocol
A selective growth hormone secretagogue studied for its potential role in sleep quality, recovery, and natural GH pulse support — without significant cortisol or prolactin elevation in research models.
Ipamorelin has been studied in relation to sleep quality, recovery, and natural growth hormone support. Some research suggests it may support deeper sleep and workout recovery. Results depend on individual patient profile and are assessed by your prescribing physician.
- Typical dose: 200–300 mcg before bed
- Frequency: Daily, 30 min before sleep
- Cycle: 8–12 weeks on, 4 weeks off
- Purity: 99.1%
- Storage: Freeze unmixed (-18°C). Refrigerate reconstituted (2–8°C), use within 30 days.
What is Ipamorelin?
Ipamorelin is a growth hormone secretagogue, a peptide that stimulates the release of growth hormone by binding to ghrelin receptors in the pituitary gland. It is noted in research for its selectivity: studies suggest it produces fewer side effects related to cortisol and prolactin elevation than earlier growth hormone-releasing peptides. In the UAE, Ipamorelin is available as a physician-supervised protocol through UAE Peptide Clinic, typically prescribed for sleep quality, recovery, and natural GH pulse support.
Ipamorelin and sleep quality
The most commonly discussed application of Ipamorelin concerns sleep quality and overnight recovery. Growth hormone is predominantly released during deep sleep stages. Some researchers and clinicians have explored whether taking a low-dose GH secretagogue before bed may align with the body's natural GH pulse timing, supporting deeper sleep and improved morning recovery. This application is assessed on a case-by-case basis by your prescribing physician.
Ipamorelin protocols in the UAE
Ipamorelin is prescribed following a physician consultation at UAE Peptide Clinic. A standard protocol involves 200 to 300 mcg administered approximately 30 minutes before sleep, daily or as directed by your physician. It is supplied in pharmaceutical-grade vials, cold-chain delivered across Dubai, Abu Dhabi, and all UAE emirates. Many patients use it alongside CJC-1295 as part of a combined GH-support protocol, though any combination requires physician approval.
Who explores Ipamorelin in the UAE?
Patients in Dubai who enquire about Ipamorelin typically include professionals experiencing disrupted sleep, athletes focused on overnight recovery, and those incorporating GH-support into a broader longevity protocol. It is one of the most accessible entry points into growth hormone-related peptide therapy, with a well-established research profile and a lower side-effect burden compared to earlier secretagogues.
- Prescription required — DHA physician consultation included
- Typical dose: 200 to 300 mcg, taken 30 minutes before sleep
- Cycle: 8 to 12 weeks on, 4 weeks off
- Available in vial format
- Can be combined with CJC-1295 as directed by physician